Fungal and Bacterial Cellular Processes

"Fungal and bacterial cellular processes" refer to essential biochemical, metabolic, and structural activities that underlie growth, division, survival, and pathogenicity of fungi and bacteria. Key targets for antimicrobial drug development include cell wall biosynthetic pathways (e.g., chitin, β-glucan, peptidoglycan synthesis), membrane integrity (e.g., ergosterol, phospholipid composition), metabolic enzymes (e.g., GMP synthase, cytochrome Bc1 reductase), and regulatory signal transduction pathways. These processes are not unique molecular entities but represent broad, multi-component systems. Therapeutic targeting of these pathways is foundational for antimicrobial therapy, but the term itself is not a valid or specific molecular target for drugs or biomarker discovery[1][2][3][4][5][6][8][9].

Inhibition of cell wall biosynthesis (e.g., chitin, β-glucan) - Disruption of cell membrane integrity (e.g., targeting ergosterol, phospholipids) - Inhibition of key enzymes (e.g., lanosterol demethylase, proteasome, casein kinases) - Inhibition of protein or nucleic acid synthesis - Interference with metabolic pathways